3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Unknown
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
1
Conditions
Breast Neoplasms
21
Neoplasm Metastasis
17
Lung Neoplasms
10
Carcinoma, Hepatocellular
10
Prostatic Neoplasms
9
Melanoma
9
Carcinoma, Renal Cell
9
Carcinoma, Non-Small-Cell Lung
9
Liver Neoplasms
8
Sarcoma
7
Kidney Neoplasms
7
Pain
6
Colorectal Neoplasms
5
Esophageal Neoplasms
4
Triple Negative Breast Neoplasms
3
Thyroid Neoplasms
3
Small Cell Lung Carcinoma
3
Osteosarcoma
3
Keratosis, Actinic
3
Cholangiocarcinoma
3
Carcinoma, Ductal, Breast
3
Uterine Cervical Neoplasms
2
Urinary Bladder Neoplasms
2
Tongue Neoplasms
2
Pancreatic Neoplasms
2
Ovarian Neoplasms
2
Neoplasms
2
Desmoid Tumors
2
Colonic Neoplasms
2
Carcinoma, Transitional Cell
2
Interventions
Gemcitabine
4
lenvatinib
3
durvalumab
3
Cisplatin
3
tislelizumab
2
sintilimab
2
pembrolizumab
2
toripalimab
1
titanium silicide
1
theasinensin A
1
surufatinib
1
sitravatinib
1
regorafenib
1
S 1 (combination)
1
Nivolumab
1
Injections
1
Folfox protocol
1
Fluorouracil
1
Cryosurgery
1
Bevacizumab
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Interventional
×
Advanced Biliary Tract Cancer
×
Cryosurgery
×
Clear all
NCT05781074
2023-03-24
CASTLE-08
Fudan University
Phase 2
Unknown
25 enrolled